SCHEMBL8939239

SCHEMBL8939239

c1ncc2[nH]c(C3CCCCN3)nc2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 5/20 0.43
AURKA O14965 1/20 0.41
SCN10A Q9Y5Y9 1/20 0.40
MEN1 O00255 2/20 0.40
CYP2D6 P10635 2/20 0.40
CYP2C19 P33261 2/20 0.40
KMT2A Q03164 2/20 0.40
CHRNB2 P17787 2/20 0.40
CHRNA7 P36544 2/20 0.40
CHRNA4 P43681 2/20 0.40
POLB P06746 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2A6 P11509 1/20 0.40
CYP2C9 P11712 1/20 0.40
METAP2 P50579 1/20 0.37
METAP1 P53582 1/20 0.37
CDC7 O00311 6/20 0.35
CCNE1 P24864 6/20 0.35
CDK2 P24941 6/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2951836 0.80 NPC1 (0.41) PARP1METAP2METAP1GRIN2B
SCHEMBL10600439 0.79 NPC1 (0.43) PARP1CYP2D6CYP2C9METAP2METAP1
Hydrochloric Acid SCHEMBL6821628 0.79 KDM4E (0.42) PARP1METAP2METAP1GRIN2B
SCHEMBL1375990 0.77 METAP2 (0.41) PARP1METAP2METAP1GRIN2B
SCHEMBL19553769 0.77 METAP2 (0.43) PARP1POLBMETAP2METAP1GRIN2B
SCHEMBL12921851 0.75 PARP1 (0.49) PARP1METAP2METAP1GRIN2B
SCHEMBL2002532 0.73 GRIN2B (0.46) GRIN2B
SCHEMBL4373720 0.72 PARP1 (0.43) PARP1METAP2METAP1GRIN2B
SCHEMBL9854786 0.72 GRIN2B (0.49) GRIN2B
SCHEMBL2388904 0.71 GRIN2B (0.47) GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5574149-A Method of treating HIV infections with 2',3'-dideoxy-3'-fluoro-5-chlorouridine GLAXO WELLCOME INC. (US) 1996-11-12 US disclosed
EP-0670328-A1 Therapeutic nucleosides THE WELLCOME FOUNDATION LIMITED (GB) 1995-09-06 EP disclosed
EP-0669341-A1 Therapeutic Nucleosides THE WELLCOME FOUNDATION LIMITED (GB) 1995-08-30 EP disclosed
EP-0317128-A2 Anti-HIV Pyrimidine Nucleosides THE WELLCOME FOUNDATION LIMITED (GB) 1989-05-24 EP disclosed